Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages.
Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages.
复制标题
DOI:
10.1371/journal.pone.0186169
复制
发表时间:
2017
期刊:
影响因子:
3.7
通讯作者:
Kopp BT
中科院分区:
文献类型:
--
作者:
Shrestha CL;Assani KD;Rinehardt H;Albastroiu F;Zhang S;Shell R;Amer AO;Schlesinger LS;Kopp BT
Members of the Burkholderia cepacia complex are virulent, multi-drug resistant pathogens that survive and replicate intracellularly in patients with cystic fibrosis (CF). We have discovered that B. cenocepacia cannot be cleared from CF macrophages due to defective autophagy, causing continued systemic inflammation and infection. Defective autophagy in CF is mediated through constitutive reactive oxygen species (ROS) activation of transglutaminase-2 (TG2), which causes the sequestration (accumulation) of essential autophagy initiating proteins. Cysteamine is a TG2 inhibitor and proteostasis regulator with the potential to restore autophagy. Therefore, we sought to examine the impact of cysteamine on CF macrophage autophagy and bacterial killing. Human peripheral blood monocyte-derived macrophages (MDMs) and alveolar macrophages were isolated from CF and non-CF donors. Macrophages were infected with clinical isolates of relevant CF pathogens. Cysteamine caused direct bacterial growth killing of live B. cenocepacia, B. multivorans, P. aeruginosa and MRSA in the absence of cells. Additionally, B. cenocepacia, B. multivorans, and P. aeruginosa invasion were significantly decreased in CF MDMs treated with cysteamine. Finally, cysteamine decreased TG2, p62, and beclin-1 accumulation in CF, leading to increased Burkholderia uptake into autophagosomes, increased macrophage CFTR expression, and decreased ROS and IL-1β production. Cysteamine has direct anti-bacterial growth killing and improves human CF macrophage autophagy resulting in increased macrophage-mediated bacterial clearance, decreased inflammation, and reduced constitutive ROS production. Thus, cysteamine may be an effective adjunct to antibiotic regimens in CF.
登录
查看更多内容
DOI:
10.1016/j.bbrc.2012.06.066
发表时间:
2012-07-27
影响因子:
3.1
作者:
Kopp, Benjamin T.;Abdulrahman, Basant A.;Amer, Amal O.
通讯作者:
Amer, Amal O.
影响因子:
5.3
作者:
Bruscia EM;Bonfield TL
通讯作者:
Bonfield TL
DOI:
10.1073/pnas.1000041107
发表时间:
2010-02-23
影响因子:
11.1
作者:
Helaine, Sophie;Thompson, Jessica A.;Holden, David W.
通讯作者:
Holden, David W.
影响因子:
5.5
作者:
Kotrange, Sheetal;Kopp, Benjamin;Amer, Amal O.
通讯作者:
Amer, Amal O.
影响因子:
13.3
作者:
Luciani, Alessandro;Villella, Valeria Rachela;Maiuri, Luigi
通讯作者:
Maiuri, Luigi